Notably, this pathogenetic loop can be attenuated in the animal model using a PPAR-γ modulator, GED, endorsing the protective role of PPAR-γ in colon homeostasis and the use of its modulator for the treatment of patients suffering from IBD. This evidence concerns the gene PPARG and inflammatory bowel disease.